It is worth mentioning that EGFR and GD2 are reported to be expressed on many other tumors beside GBM, such as melanoma and neuroblastoma, and therefore, our approach can be extended in the future to target such tumors (32, 71, 72). The gene discussed is EGFR; the disease is glioblastoma.